GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » Other Current Receivables

GeneTether Therapeutics (XCNQ:GTTX) Other Current Receivables : C$0.06 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics Other Current Receivables?

GeneTether Therapeutics's Other Current Receivables for the quarter that ended in Dec. 2023 was C$0.06 Mil.

GeneTether Therapeutics's quarterly Other Current Receivables declined from Jun. 2023 (C$0.19 Mil) to Sep. 2023 (C$0.12 Mil) but then stayed the same from Sep. 2023 (C$0.12 Mil) to Dec. 2023 (C$0.06 Mil).

GeneTether Therapeutics's annual Other Current Receivables increased from Dec. 2021 (C$0.00 Mil) to Dec. 2022 (C$0.20 Mil) but then declined from Dec. 2022 (C$0.20 Mil) to Dec. 2023 (C$0.06 Mil).


GeneTether Therapeutics Other Current Receivables Historical Data

The historical data trend for GeneTether Therapeutics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics Other Current Receivables Chart

GeneTether Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Current Receivables
- - 0.20 0.06

GeneTether Therapeutics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.02 0.19 0.12 0.06

GeneTether Therapeutics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


GeneTether Therapeutics Other Current Receivables Related Terms

Thank you for viewing the detailed overview of GeneTether Therapeutics's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneTether Therapeutics (XCNQ:GTTX) Business Description

Traded in Other Exchanges
N/A
Address
301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, V1Y 2B3
GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin.

GeneTether Therapeutics (XCNQ:GTTX) Headlines

No Headlines